Published in Eur J Gastroenterol Hepatol on January 01, 2005
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ (2007) 3.28
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Coeliac disease in systemic lupus erythematosus: a case report. Rheumatol Int (2007) 1.55
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut (2006) 1.51
Early microbial markers of celiac disease. J Clin Gastroenterol (2014) 1.48
Celiac disease and autoimmune thyroid disease. Clin Med Res (2007) 1.42
Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable? World J Gastroenterol (2010) 1.41
Adult coeliac disease. BMJ (2007) 1.30
Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology (2010) 1.29
What is the best histopathological classification for celiac disease? Does it matter? Gastroenterol Hepatol Bed Bench (2015) 1.27
Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests. BMC Gastroenterol (2013) 1.19
Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One (2013) 1.13
A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. BMC Med (2013) 1.11
Celiac disease. Orphanet J Rare Dis (2006) 1.05
Diagnostic criteria for coeliac disease: time for change? Eur J Gastroenterol Hepatol (2005) 0.98
Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol (2008) 0.95
Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa. World J Gastroenterol (2007) 0.93
Clinical practice : coeliac disease. Eur J Pediatr (2012) 0.92
Diagnosis of celiac disease. Gastrointest Endosc Clin N Am (2012) 0.88
Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding. Gut (2006) 0.84
Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2. J Clin Immunol (2011) 0.83
Clinical utility of celiac disease-associated HLA testing. Dig Dis Sci (2014) 0.83
Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation. World J Gastroenterol (2012) 0.83
Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci (2007) 0.83
Limited utilization of serologic testing in patients undergoing duodenal biopsy for celiac disease. BMC Gastroenterol (2013) 0.78
Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies. Dig Dis Sci (2010) 0.78
Celiac disease in adult patients: specific autoantibodies in the diagnosis, monitoring, and screening. Autoimmune Dis (2014) 0.78
Sero-negative celiac disease with dermatitis herpetiformes: a case report. Cases J (2009) 0.77
Serum markers in the clinical management of celiac disease. Dig Dis (2015) 0.76
Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review. Front Med (Lausanne) (2014) 0.76
Difficulties in Celiac Disease Diagnosis in Children - A case report. Maedica (Buchar) (2011) 0.75
Cost effectiveness of routine duodenal biopsies in iron deficiency anemia. World J Gastroenterol (2016) 0.75
A Canadian Study toward Changing Local Practice in the Diagnosis of Pediatric Celiac Disease. Can J Gastroenterol Hepatol (2016) 0.75
Clinical utility of quantitative multi-antibody Polycheck immunoassays in the diagnosis of coeliac disease. World J Gastrointest Pharmacol Ther (2016) 0.75
Celiac disease: clinch the diagnosis when it is just around the corner. Dig Dis Sci (2013) 0.75
Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North American Practices Without Intestinal Biopsies. Dig Dis Sci (2016) 0.75
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50
Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet (2008) 7.63
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med (2014) 4.64
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr (2007) 3.91
Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med (2012) 3.35
A prospective study comparing video capsule endoscopy with double-balloon enteroscopy in patients with obscure gastrointestinal bleeding. Am J Gastroenterol (2006) 3.27
Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology (2002) 2.99
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol (2012) 2.93
The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med (2010) 2.84
Clinical practice. Celiac disease. N Engl J Med (2012) 2.79
Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet (2005) 2.71
Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening. J Pediatr Gastroenterol Nutr (2015) 2.58
The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology (2002) 2.58
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med (2002) 2.49
Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest (2005) 2.41
Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med (2014) 2.39
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33
Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med (2007) 2.26
Celiac disease without villous atrophy in children: a prospective study. J Pediatr (2010) 2.24
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis. Liver Int (2014) 2.23
Burden of illness in screen-detected children with celiac disease and their families. J Pediatr Gastroenterol Nutr (2012) 2.20
Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet (2009) 2.15
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet (2004) 2.06
Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol (2006) 2.04
Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology (2002) 2.02
Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease. Clin Gastroenterol Hepatol (2013) 2.00
Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology (2008) 1.93
European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol (2006) 1.92
Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol (2003) 1.92
Issues associated with the emergence of coeliac disease in the Asia–Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of Gastroenterology. J Gastroenterol Hepatol (2014) 1.83
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis (2005) 1.83
Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet (2010) 1.81
Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase. Chem Biol (2003) 1.81
Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol (2002) 1.81
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol (2006) 1.81
Risk of non-Hodgkin lymphoma in celiac disease. JAMA (2002) 1.81
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest (2010) 1.79
Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr (2009) 1.79
The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol (2010) 1.77
Usefulness of symptoms to screen for celiac disease. Pediatrics (2014) 1.75
Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One (2012) 1.74
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients (2013) 1.74
Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet (2010) 1.71
Endocrinological disorders and celiac disease. Endocr Rev (2002) 1.71
Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol (2010) 1.70
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol (2009) 1.70
A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology (2003) 1.69
How do Swedish paediatric clinics diagnose coeliac disease? Results of a nationwide questionnaire study. Acta Paediatr (2006) 1.67
Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol (2009) 1.65
Refractory coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.61
Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups. J Pediatr Gastroenterol Nutr (2012) 1.60
Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol (2002) 1.60
Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol (2005) 1.58
HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol (2002) 1.58
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol (2012) 1.58
Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis. J Am Diet Assoc (2004) 1.58
Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing. J Pediatr Gastroenterol Nutr (2013) 1.58
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver Int (2013) 1.57
Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One (2009) 1.56
Might gluten traces in wheat substitutes pose a risk in patients with celiac disease? A population-based probabilistic approach to risk estimation. Am J Clin Nutr (2012) 1.56
Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev (2010) 1.55
Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. Arthritis Rheum (2011) 1.54
Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment. Am J Gastroenterol (2003) 1.54
A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest (2005) 1.54
Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol (2014) 1.54
Gastroenterology in developing countries: issues and advances. World J Gastroenterol (2009) 1.53
Nutritional management of the gluten-free diet in young people with celiac disease in The Netherlands. J Pediatr Gastroenterol Nutr (2006) 1.52
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut (2012) 1.52
Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol (2006) 1.51